Clinical Trial Update: Prospective Huntington At Risk Observational Study

View source ↗

Summary

The Prospective Huntington At Risk Observational Study sponsored by the Huntington Study Group has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: Huntington Study Group | Conditions: Huntington Disease | Status: COMPLETED